Raymond James on Doximity Inc (DOCS): 'We still believe that Doximity’s reach of 80%+ of physicians on the platform represents a formidable moat'

September 17, 2025 12:50 PM EDT Send to a Friend
Raymond James analyst Brian Peterson reiterated an Outperform rating and $75.00 price target on Doximity Inc (NYSE: DOCS)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login